India Today on MSN3d
Mankind Pharma launches generic for popular diabetes drug at one-tenth the cost
Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...
Verywell Health on MSN11mon
Jardiance vs. Farxiga: Similarities and Differences
Jardiance comes in the following tablet strengths: 10 milligrams (mg) and 25 mg Farxiga comes in the following tablet ...
Pharmabiz2d
Mankind Pharma launches affordable empagliflozin in India for diabetes
Mankind Pharma launches affordable empagliflozin in India for diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:30 Hrs [IST] Mankind Pharma has launched its affordable gen ...
Day 1 after diabetes drug Empagliflozin goes off patent, generics go to town with it
Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.
pharmaphorum3y
FDA approves Jardiance (empagliflozin) for wider range of patients with heart failure
Jardiance is also authorised to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. According to the FDA, heart disease impacts more than ...
pharmaphorum2d
FDA fast-tracks Lilly/Boehringer’s Jardiance in chronic kidney disease
The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential new use, to reduce the risk of renal failure and cardiovascular death in people with chronic ...
New affordable diabetes drug Empagliflozin launched in India
Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly ...
moneycontrol.com2d
Prices of diabetes drug empagliflozin falls by 80-90% as generics enter market
The launches follows patent expiration of empagliflozin sold by German drugmaker Boehringer Ingelheim under brand name Jardiance ... the 10 mg variant and Rs 9.9 per tablet for the 25 mg variant ...